Welcome to our dedicated page for James Hardie Industries plc SEC filings (Ticker: JHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
James Hardie Industries plc filings document foreign-issuer disclosure for an Irish building-products company listed on the NYSE and ASX. Recent Form 6-K reports furnish ASX announcements, earnings-release timing, annual general meeting materials, voting results, substantial-holder notices, director interest notices and securities quotation or unquoted-security notifications.
The filing record ties governance and ownership disclosures to the company’s board, substantial holdings and equity-security activity, while periodic communications describe results reporting, forward-looking statement legends and the company’s exterior home and outdoor living products portfolio. These records also identify the company as an Irish public limited company governed under the Irish Companies Act.
James Hardie Industries plc (JHX) reported that director Renee J. Peterson received a grant of 743 ordinary shares on September 15, 2026, recorded as a grant or award acquisition. The shares were issued at a stated price of $0.00 per share under the issuer's Non-Executive Director Compensation Program.
Following this award, Peterson now directly holds 42,605 ordinary shares of James Hardie Industries plc. No Rule 10b5-1 trading plan is reported for this transaction.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Hendrickson Gary E reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Gary E. Hendrickson received a grant of 1,140 ordinary shares on September 15, 2026, issued pursuant to the issuer's Non-Executive Director Compensation Program and at no cash purchase price. Following this award, he holds 26,314 ordinary shares directly, with additional ordinary shares held indirectly by a trust.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Rowland Suzanne B reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Suzanne B. Rowland received a grant of 748 ordinary shares on September 15, 2026, issued under the company’s Non-Executive Director Compensation Program. Following this award, she directly holds 17,049 ordinary shares of the company.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Stein Nigel reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Nigel Stein received a grant of 903 ordinary shares on September 15, 2026 under the company's Non-Executive Director Compensation Program. Following this award, he directly holds 41,936 ordinary shares of James Hardie Industries plc.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Singh Jesse G reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Jesse G. Singh received a grant of 744 ordinary shares on September 15, 2026 under the company’s Non-Executive Director Compensation Program, at a stated price of $0.00 per share. Following this award, he holds 117,772 ordinary shares directly, in addition to ordinary shares held indirectly through several family and estate-planning trusts. No transactions in this filing are reported as made under a Rule 10b5-1 trading plan.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. HECKES HOWARD C reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Howard C. Heckes received an award of 1,268 ordinary shares on September 15, 2026 under the company’s Non-Executive Director Compensation Program. Following this award, he holds 29,151 ordinary shares directly, plus additional shares held indirectly through a trust for which he serves as trustee.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Pfeifer John C reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director John C. Pfeifer received a grant of 751 ordinary shares on September 15, 2026, issued at $0.00 per share pursuant to the issuer's Non-Executive Director Compensation Program. Following this award, Pfeifer directly holds 6,112 ordinary shares. No Rule 10b5-1 trading plan is reported for this transaction.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Sindel Alan Robert Harold reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Alan Robert Harold Sindel received a grant of 1,224 ordinary shares on September 15, 2026 under the company’s Non-Executive Director Compensation Program. The award was recorded at $0.00 per share, bringing his directly held position to 1,714 ordinary shares.
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA. On 2026-08-25 he exercised 50,000 employee stock options with an exercise price of $11.23 per share, which had been assumed in connection with the acquisition of The AZEK Company Inc. and were exercisable as of July 1, 2025. He then sold a total of 65,000 ordinary shares in open-market transactions at weighted average prices of approximately $30.45 and $30.46 per share, including 50,000 shares sold through a broker-assisted cashless exercise. Following the derivative transaction, he held 287,721 employee stock options directly.
James Hardie Industries plc (JHX) is the issuer for which officer Jonathan Skelly has filed a notice of proposed sale of up to 65,000 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,979,094.56 as of the notice date. The 65,000 shares consist of 15,000 shares acquired in a merger on 07/02/2025 and 50,000 shares acquired through a stock option exercise on 08/25/2026, both from the issuer. Shares outstanding were 580,522,488 as of 08/25/2026; this is a baseline figure, not the amount being sold.